Latanoprost/Timolol Elvim (Timolol Maleate, Latanoprost)

The timolol component blocks beta‑adrenergic receptors in the ciliary body, decreasing aqueous humor production. Latanoprost, a prostaglandin analog, enhances uveoscleral outflow of aqueous humor. Together, they provide a synergistic reduction of intra‑ocular pressure.

The prescribed dose is determined by the treating ophthalmologist based on the patient’s condition and response. Typically, one drop is instilled into the affected eye(s) once daily, but the exact regimen should follow the prescriber’s instructions.

The pregnancy category for this combination is unknown, and safety data are limited. It should only be used if the potential benefit justifies the potential risk to the fetus. Caution is advised during breastfeeding, as the drug may be excreted in milk.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the team will provide pricing, availability, shipping details, and any required import documentation.

Compared with single‑agent therapies, the combination offers greater intra‑ocular pressure reduction than either timolol or latanoprost alone. It may be preferred when monotherapy does not achieve target pressure, reducing the need for multiple eye drops and improving patient adherence.

Store the eye‑drop bottle at room temperature, below 25 °C. Keep it tightly closed, protect from light, and avoid exposure to moisture. Do not freeze the product.

The medication is applied as a single drop into the affected eye(s) once daily, preferably in the evening. The patient should avoid touching the tip of the bottle to the eye or any other surface to maintain sterility.

Serious risks include severe allergic reactions, sudden loss of vision, marked bradycardia, bronchospasm, and systemic hypotension. Patients should seek immediate medical attention if they experience any of these symptoms.

The product should be avoided in patients with known hypersensitivity to timolol, latanoprost, or any excipients, as well as those with severe asthma, chronic obstructive pulmonary disease, sinus bradycardia, or certain cardiac conduction disorders.